Long-lasting CRs after ibrutinib monotherapy for relapse or refractory primary CNS lymphoma (PCNSL) and primary vitreoretinal lymphoma (PVRL): Long-term results of the iLOC study by the Lymphoma Study Association (LYSA) and the French Oculo-Cerebral Lymphoma (LOC) Network (clinical trial number: NCT02542514).
Eur J Cancer
; 189: 112909, 2023 08.
Article
em En
| MEDLINE
| ID: mdl-37301714
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias do Sistema Nervoso Central
/
Neoplasias da Retina
/
Linfoma
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article